{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:12:08Z","timestamp":1790187128657,"version":"4.1.0"},"reference-count":52,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/vzjl1218","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T09:32:32Z","timestamp":1712223152000},"page":"781-793","source":"Crossref","is-referenced-by-count":11,"title":["Electroacupuncture protects the intestinal mucosal barrier in diarrhea-predominant Irritable Bowel Syndrome rats by regulating the MCs\/Tryptase\/PAR-2\/MLCK pathway"],"prefix":"10.62347","volume":"16","author":[{"given":"Xiao-Yu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MED.0000000000000720","article-title":"Irritable bowel syndrome and diet","volume":"29","author":"Weber","year":"2022","unstructured":"Weber HC. Irritable bowel syndrome and diet. Curr Opin Endocrinol Diabetes Obes 2022; 29: 200-206.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3748\/wjg.v28.i4.412","article-title":"Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome","volume":"28","author":"EMR","year":"2022","unstructured":"Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A and Berentsen B. Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28: 412-431.","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3390\/cells11132046","article-title":"Mucosal plasma cell activation and proximity to nerve fibres are associated with glycocalyx reduction in diarrhoea-predominant irritable bowel syndrome: jejunal barrier alterations underlying clinical manifestations","volume":"11","author":"Pardo-Camacho C","year":"2022","unstructured":"Pardo-Camacho C, Ganda Mall JP, Martínez C, Pigrau M, Expósito E, Albert-Bayo M, Melón-Ardanaz E, Nieto A, Rodiño-Janeiro B, Fortea M, Guagnozzi D, Rodriguez-Urrutia A, Torres I, Santos-Briones I, Azpiroz F, Lobo B, Alonso-Cotoner C, Santos J, González-Castro AM and Vicario M. Mucosal plasma cell activation and proximity to nerve fibres are associated with glycocalyx reduction in diarrhoea-predominant irritable bowel syndrome: jejunal barrier alterations underlying clinical manifestations. Cells 2022; 11: 2046.","journal-title":"Cells"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11726-022-1343-3","article-title":"Effects of moxibustion on miRNA-133b, Pitx3\/TH, and neurotransmitters in the midbrain of rats with diarrhea-predominant irritable bowel syndrome","volume":"20","author":"Chen","year":"2022","unstructured":"Chen JY, Wang JJ, Zou L, Zhu SS, Li KW, Liao LM, Ruan JR, Chu HR and Yang YP. Effects of moxibustion on miRNA-133b, Pitx3\/TH, and neurotransmitters in the midbrain of rats with diarrhea-predominant irritable bowel syndrome. Journal of Acupuncture and Tuina Science 2022; 20: 433-445.","journal-title":"Journal of Acupuncture and Tuina Science"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Sebastián Domingo JJ. Irritable bowel syndrome. Med Clin (Barc) 2022; 158: 76-81.","DOI":"10.1016\/j.medcle.2021.04.015"},{"key":"ref5","unstructured":"Pimentel M. Evidence-based management of irritable bowel syndrome with diarrhea. Am J Manag Care 2018; 24 Suppl: S35-S46."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.dld.2009.07.009","article-title":"Current and novel therapeutic options for irritable bowel syndrome management","volume":"41","author":"Camilleri","year":"2009","unstructured":"Camilleri M and Andresen V. Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis 2009; 41: 854-862.","journal-title":"Dig Liver Dis"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Liu J, Peng R, Tan Q, Li B, Chen J, Liu G, Wang Y, Li C, Li J and Wang H. Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea. PLoS One 2022; 17: e0273853.","DOI":"10.1371\/journal.pone.0273853"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.3748\/wjg.v13.i25.3417","article-title":"Acupuncture treatment in gastrointestinal diseases: a systematic review","volume":"13","author":"Schneider","year":"2007","unstructured":"Schneider A, Streitberger K and Joos S. Acupuncture treatment in gastrointestinal diseases: a systematic review. World J Gastroenterol 2007; 13: 3417-3424.","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1010484","DOI":"10.3389\/fphar.2022.1010484","article-title":"Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats","volume":"13","author":"Yu","year":"2023","unstructured":"Yu L, Huang C, Yang W, Ren Z, Li L, Cheng H, Lin C, Zhai L, Ning Z, Wong HX, Han Q, Jia W, Bian Z and Zhao L. Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats. Front Pharmacol 2023; 13: 1010484.","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Wang L, Xian J, Sun M, Wang X, Zang X, Zhang X, Yu H and Tan QW. Acupuncture for emotional symptoms in patients with functional gastrointestinal disorders: a systematic review and meta-analysis. PLoS One 2022; 17: e0263166.","DOI":"10.1371\/journal.pone.0263166"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5582\/bst.2022.01039","article-title":"Revealing the magic of acupuncture based on biological mechanisms: a literature review","volume":"16","author":"Zhang","year":"2022","unstructured":"Zhang B, Shi H, Cao S, Xie L, Ren P, Wang J and Shi B. Revealing the magic of acupuncture based on biological mechanisms: a literature review. Biosci Trends 2022; 16: 73-90.","journal-title":"Biosci Trends"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"8892184","DOI":"10.1155\/2020\/8892184","article-title":"Acupuncture for adults with diarrhea-predominant irritable bowel syndrome or functional diarrhea: a systematic review and meta-analysis","volume":"2020","author":"Guo","year":"2020","unstructured":"Guo J, Xing X, Wu J, Zhang H, Yun Y, Qin Z and He Q. Acupuncture for adults with diarrhea-predominant irritable bowel syndrome or functional diarrhea: a systematic review and meta-analysis. Neural Plast 2020; 2020: 8892184.","journal-title":"Neural Plast"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2036.2004.02196.x","article-title":"Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders","volume":"20","author":"Ouyang","year":"2004","unstructured":"Ouyang H and Chen JD. Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20: 831-841.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Zheng H, Xu J, Sun X, Zeng F, Li Y, Wu X, Li J, Zhao L, Chang XR, Liu M, Gong B, Li XZ and Liang FR. Electroacupuncture for patients with refractory functional dyspepsia: a randomized controlled trial. Neurogastroenterol Motil 2018; 30: e13316.","DOI":"10.1111\/nmo.13316"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1111\/jgh.15645","article-title":"Acupuncture for functional gastrointestinal disorders: a systematic review and meta-analysis","volume":"36","author":"Wang","year":"2021","unstructured":"Wang XY, Wang H, Guan YY, Cai RL and Shen GM. Acupuncture for functional gastrointestinal disorders: a systematic review and meta-analysis. J Gastroenterol Hepatol 2021; 36: 3015-3026.","journal-title":"J Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/MCG.0000000000001455","article-title":"Acupuncture and related therapies for the treatment of gastrointestinal diseases","volume":"55","author":"Rabitti","year":"2021","unstructured":"Rabitti S, Giovanardi CM and Colussi D. Acupuncture and related therapies for the treatment of gastrointestinal diseases. J Clin Gastroenterol 2021; 55: 207-217.","journal-title":"J Clin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Wang X, Huang M, Yang H, Zhang D, Yao W, Xia Y and Ding G. Mast cell degranulation and adenosine release: acupoint specificity for effect of electroacupuncture on pituitrin-induced acute heart bradycardia in rabbits. Evid Based Complement Alternat Med 2020; 2020: 1348914.","DOI":"10.1155\/2020\/1348914"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.2147\/JIR.S341581","article-title":"The anti-inflammatory actions and mechanisms of acupuncture from acupoint to target organs via neuro-immune regulation","volume":"14","author":"Li","year":"2021","unstructured":"Li N, Guo Y, Gong Y, Zhang Y, Fan W, Yao K, Chen Z, Dou B, Lin X, Chen B, Chen Z, Xu Z and Lyu Z. The anti-inflammatory actions and mechanisms of acupuncture from acupoint to target organs via neuro-immune regulation. J Inflamm Res 2021; 14: 7191-7224.","journal-title":"J Inflamm Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40659-020-00279-2","article-title":"Mast cells-derived MiR-223 destroys intestinal barrier function by inhibition of CLDN8 expression in intestinal epithelial cells","volume":"53","author":"Li","year":"2020","unstructured":"Li M, Zhao J, Cao M, Liu R, Chen G, Li S, Xie Y, Xie J, Cheng Y, Huang L, Su M, Xu Y, Zheng M, Zou K, Geng L, Xu W and Gong S. Mast cells-derived MiR-223 destroys intestinal barrier function by inhibition of CLDN8 expression in intestinal epithelial cells. Biol Res 2020; 53: 12.","journal-title":"Biol Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00418-018-1659-8","article-title":"Tryptase as a polyfunctional component of mast cells","volume":"149","author":"Atiakshin","year":"2018","unstructured":"Atiakshin D, Buchwalow I, Samoilova V and Tiemann M. Tryptase as a polyfunctional component of mast cells. Histochem Cell Biol 2018; 149: 461-477.","journal-title":"Histochem Cell Biol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2982.2008.01139.x","article-title":"Protease-activated receptor 2 and gut permeability: a review","volume":"20","author":"Bueno","year":"2008","unstructured":"Bueno L and Fioramonti J. Protease-activated receptor 2 and gut permeability: a review. Neurogastroenterol Motil 2008; 20: 580-587.","journal-title":"Neurogastroenterol Motil"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1039\/D0FO02848G","article-title":"Puerarin from Pueraria lobata alleviates the symptoms of irritable bowel syndrome-diarrhea","volume":"12","author":"Wang","year":"2021","unstructured":"Wang QS, Wang YL, Zhang WY, Li KD, Luo XF and Cui YL. Puerarin from Pueraria lobata alleviates the symptoms of irritable bowel syndrome-diarrhea. Food Funct 2021; 12: 2211-2224.","journal-title":"Food Funct"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10863-020-09850-8","article-title":"CADM1 enhances intestinal barrier function in a rat model of mild inflammatory bowel disease by inhibiting the STAT3 signaling pathway","volume":"52","author":"Sun","year":"2020","unstructured":"Sun S, Liu W and Li Y. CADM1 enhances intestinal barrier function in a rat model of mild inflammatory bowel disease by inhibiting the STAT3 signaling pathway. J Bioenerg Biomembr 2020; 52: 343-354.","journal-title":"J Bioenerg Biomembr"},{"key":"ref24","unstructured":"Li ZR. Experimental acupuncture science. Beijing: China Press of Traditional Chinese Medicine; 2011. pp. 255-257."},{"key":"ref25","unstructured":"Xu SY, Bian RL and Chen X. Pharmacological experiment methodology. Beijing: People’s Health Publishing House; 2002. pp. 202-203."},{"key":"ref26","unstructured":"Zou L, Ruan JR, Chen JY, Wang JJ, Zhu SS, Liao LM, Li KW, Wang JJ and Chu HR. Moxibustion relieves colonic inflammation by up-regulating expression of miR-345-3p\/miR-216a-5p and down-regulating NF-κB p65 in colonic tissue of rats with diarrhea-predominant irritable bowel syndrome. Zhen Ci Yan Jiu 2023; 48: 226-232."},{"key":"ref27","unstructured":"Li KW, Chu HR, Ruan JR, Wang JJ, Chen JY, Zhu SS, Zou L, Liao LM and Tong TT. Effect of moxibustion on immune function homeostasis in rats with diarrhea irritable bowel syndrome based on SCF\/c-kit signaling pathway. Zhongguo Zhen Jiu 2023; 43: 177-185."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/ibd\/izy371","article-title":"Acupuncture in inflammatory bowel disease","volume":"25","author":"Song","year":"2019","unstructured":"Song G, Fiocchi C and Achkar JP. Acupuncture in inflammatory bowel disease. Inflamm Bowel Dis 2019; 25: 1129-1139.","journal-title":"Inflamm Bowel Dis"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Qi LY, Yang JW, Yan SY, Tu JF, She YF, Li Y, Chi LL, Wu BQ and Liu CZ. Acupuncture for the treatment of diarrhea-predominant irritable bowel syndrome: a pilot randomized clinical trial. JAMA Netw Open 2022; 5: e2248817.","DOI":"10.1001\/jamanetworkopen.2022.48817"},{"key":"ref30","unstructured":"Chen YH, Chen XK and Yin XJ. Comparison of the therapeutic effects of electroacupuncture and probiotics combined with deanxit in treating diarrhea-predominant irritable bowel syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012; 32: 594-598."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ajg.2011.472","article-title":"The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations","volume":"107","author":"Mart&#xED","year":"2012","unstructured":"Martínez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C, Sánchez A, Guilarte M, Antolín M, de Torres I, González-Castro AM, Pigrau M, Saperas E, Azpiroz F and Santos J. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol 2012; 107: 736-746.","journal-title":"Am J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/gutjnl-2012-304066","article-title":"Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation","volume":"63","author":"Vivinus-N&#xE9","year":"2014","unstructured":"Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V, Hébuterne X and Piche T. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 2014; 63: 744-752.","journal-title":"Gut"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2147\/JIR.S300513","article-title":"Research on correlation between psychological factors, mast cells, and PAR-2 signal pathway in irritable bowel syndrome","volume":"14","author":"Chao","year":"2021","unstructured":"Chao G, Wang Z and Zhang S. Research on correlation between psychological factors, mast cells, and PAR-2 signal pathway in irritable bowel syndrome. J Inflamm Res 2021; 14: 1427-1436.","journal-title":"J Inflamm Res"},{"key":"ref34","unstructured":"Tang HY, Chen XQ, Wang H, Chu HR, Zhu CF, Huang S, Zhang MT and Shen GM. Acupuncture relieves the visceral pain of diarrhea-predominant irritable bowel syndrome rats by regulating P2X4 expression. Am J Transl Res 2022; 14: 5563-5573."},{"key":"ref35","unstructured":"Hou YJ, Wang K, Jiang HL, Chen Y, Yao JP, Li Y and Zhou SY. Study on the mechanism of electroacupuncture repairing intestinal barrier via regulating mast cell in rats with diarrhea-predominant irritable bowel syndrome. Zhen Ci Yan Jiu 2023; 48: 281-286."},{"key":"ref36","unstructured":"Yang NN, Ma X, Li YJ, Yang JW, Li HP, Zhang YQ and Liu CZ. Research progress and thinking of acupuncture in anti-inflammation by regulating autonomic nerve system. Zhen Ci Yan Jiu 2023; 48: 610-617."},{"key":"ref37","unstructured":"Chao YQ, Chen BW, Chen SZ and Hou Y. Re-thinking the acupoint-visceral correlation: evidence from clinical literature and its biological mechanism. Zhen Ci Yan Jiu 2023; 48: 37-43."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1002\/ar.25102","article-title":"Adrenal sympathetic nerve mediated the anti-inflammatory effect of electroacupuncture at ST25 acupoint in a rat model of sepsis","volume":"306","author":"Zhang","year":"2023","unstructured":"Zhang Z, Cui X, Liu K, Gao X, Zhou Q, Xi H, Zhao Y, Zhang D and Zhu B. Adrenal sympathetic nerve mediated the anti-inflammatory effect of electroacupuncture at ST25 acupoint in a rat model of sepsis. Anat Rec (Hoboken) 2023; 306: 3178-3188.","journal-title":"Anat Rec (Hoboken)"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1254\/jphs.FMJ04005X3","article-title":"Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase\/PAR-2 in vascular endothelial barrier function","volume":"97","author":"Itoh","year":"2005","unstructured":"Itoh Y, Sendo T and Oishi R. Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase\/PAR-2 in vascular endothelial barrier function. J Pharmacol Sci 2005; 97: 14-19.","journal-title":"J Pharmacol Sci"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Jimenez-Vargas NN, Pattison LA, Zhao P, Lieu T, Latorre R, Jensen DD, Castro J, Aurelio L, Le GT, Flynn B, Herenbrink CK, Yeatman HR, Edgington-Mitchell L, Porter CJH, Halls ML, Canals M, Veldhuis NA, Poole DP, McLean P, Hicks GA, Scheff N, Chen E, Bhattacharya A, Schmidt BL, Brierley SM, Vanner SJ and Bunnett NW. Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome. Proc Natl Acad Sci U S A 2018; 115: E7438-E7447.","DOI":"10.1073\/pnas.1721891115"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/00365521.2022.2141075","article-title":"Mast cells disrupt the duodenal mucosal integrity: implications for the mechanisms of barrier dysfunction in functional dyspepsia","volume":"58","author":"Wang","year":"2023","unstructured":"Wang Z, Hao M, Wu L, He Y and Sun X. Mast cells disrupt the duodenal mucosal integrity: implications for the mechanisms of barrier dysfunction in functional dyspepsia. Scand J Gastroenterol 2023; 58: 460-470.","journal-title":"Scand J Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1248\/bpb.b18-00059","article-title":"The effect of Prim-O-glucosylcimifugin on tryptase-induced intestinal barrier dysfunction in Caco-2 cells","volume":"41","author":"Xu","year":"2018","unstructured":"Xu L, Cai J, Tian A, Qian K, Qin R, Qi S, Tan X, Qiu Y, Gong M, Han B and Hu X. The effect of Prim-O-glucosylcimifugin on tryptase-induced intestinal barrier dysfunction in Caco-2 cells. Biol Pharm Bull 2018; 41: 1355-1361.","journal-title":"Biol Pharm Bull"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"113925","DOI":"10.1016\/j.jep.2021.113925","article-title":"Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF\/c-kit and MLCK\/MLC2 pathways","volume":"272","author":"Xie","year":"2021","unstructured":"Xie Y, Zhan X, Tu J, Xu K, Sun X, Liu C, Ke C, Cao G, Zhou Z and Liu Y. Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF\/c-kit and MLCK\/MLC2 pathways. J Ethnopharmacol 2021; 272: 113925.","journal-title":"J Ethnopharmacol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/metabo12030223","article-title":"The intestinal barrier-shielding the body from nano- and microparticles in our diet","volume":"12","author":"Schwarzfischer","year":"2022","unstructured":"Schwarzfischer M and Rogler G. The intestinal barrier-shielding the body from nano- and microparticles in our diet. Metabolites 2022; 12: 223.","journal-title":"Metabolites"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"871713","DOI":"10.3389\/fimmu.2022.871713","article-title":"The role of intestinal mucosal barrier in autoimmune disease: a potential target","volume":"13","author":"An","year":"2022","unstructured":"An J, Liu Y, Wang Y, Fan R, Hu X, Zhang F, Yang J and Chen J. The role of intestinal mucosal barrier in autoimmune disease: a potential target. Front Immunol 2022; 13: 871713.","journal-title":"Front Immunol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3892\/etm.2020.9284","article-title":"Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1","volume":"20","author":"Zhu","year":"2020","unstructured":"Zhu H, Xiao X, Shi Y, Wu Y, Huang Y, Li D, Xiong F, He G, Chai Y and Tang H. Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1. Exp Ther Med 2020; 20: 155.","journal-title":"Exp Ther Med"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Zhao L, Ren P, Wang M, Wang J, He X, Gu J, Lu Y, Wu Y, Liu J, Wang L and Li H. Changes in intestinal barrier protein expression and intestinal flora in a rat model of visceral hypersensitivity. Neurogastroenterol Motil 2022; 34: e14299.","DOI":"10.1111\/nmo.14299"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/MEG.0000000000001737","article-title":"Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea","volume":"32","author":"Wang","year":"2020","unstructured":"Wang J, Wang Y, Zhou H, Gu W, Wang X and Yang J. Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea. Eur J Gastroenterol Hepatol 2020; 32: 706-712.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000362405","article-title":"Medication management of irritable bowel syndrome","volume":"89","author":"Trinkley","year":"2014","unstructured":"Trinkley KE and Nahata MC. Medication management of irritable bowel syndrome. Digestion 2014; 89: 253-267.","journal-title":"Digestion"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"8331439","DOI":"10.1155\/2022\/8331439","article-title":"Abdominal massage improves the symptoms of irritable bowel syndrome by regulating mast cells via the Trypase-PAR2-PKCε pathway in rats","volume":"2022","author":"Li","year":"2022","unstructured":"Li H, Zhang W, Ma F, Zhang X, Wang Y and Wang J. Abdominal massage improves the symptoms of irritable bowel syndrome by regulating mast cells via the Trypase-PAR2-PKCε pathway in rats. Pain Res Manag 2022; 2022: 8331439.","journal-title":"Pain Res Manag"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Ma XP, Hong J, An CP, Zhang D, Huang Y, Wu HG, Zhang CH and Meeuwsen S. Acupuncture-moxibustion in treating irritable bowel syndrome: how does it work? World J Gastroenterol 2014; 20: 6044-6054.","DOI":"10.3748\/wjg.v20.i20.6044"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/3\/ajtr0153338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:52:26Z","timestamp":1766022746000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/3\/ajtr0153338.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/vzjl1218","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}